google_counter
Treatment of neuroendocrine tumor (NET) of the appendix with Lutetium-177-DOTATATE (691153) | University Hospital Halle (Saale) - BookingHealth
{"translation_price":"50","translation_doc_price":"40","child_coefficient":"1.1","transfer_price":"2.00","transfer_price_vip":"5.00","constant_transfer_price_vip":350,"constant_transfer_price":150,"constant_transfer_distanse":60,"type":"treatment","program_full_story":"<ul>\n\t<li>Initial presentation in the hospital<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Physical examination<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>TSH, free T3, free T4<\/li>\n\t\t<li>indicators of inflammation<\/li>\n\t\t<li>coagulation tests<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Renal scintigraphy<\/li>\n\t<li>Ga-68 DOTATATE PET\/CT (if indicated)<\/li>\n\t<li>Lutetium-177-DOTATATE treatment<\/li>\n\t<li>Full body scintigraphy after 24 hours<\/li>\n\t<li>Full body scintigraphy after 48 hours<\/li>\n\t<li>Symptomatic treatment<\/li>\n\t<li>Cost of essential medicines<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Stay in the hospital with full board<\/li>\n\t<li>Accommodation in 2-bedded room<\/li>\n\t<li>Elaboration of further recommendations<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the doctor will carry out a general physical examination and go through the results of previous laboratory and instrumental tests. After that, you will undergo the necessary additional tests such as the assessment of liver and kidney function, scintigraphy of the skeleton and salivary glands, somatostatin receptor imaging with&nbsp;Ga-68 DOTATATE PET\/CT. This will allow the doctor to assess how effective the radionuclide therapy with Lutetium-177-DOTATATE will be and how well you will tolerate it. Also, the doctor will calculate your individual dosage of the radionuclide.<\/p>\n\n<p style=\"text-align:justify\"><strong>Radionuclide therapy with Lutetium-177-DOTATATE<\/strong>&nbsp;is carried out via intravenous administration of a solution with the radioactive isotope Lutetium-177-DOTATATE. The solution is injected through a catheter. This is a short procedure, as the infusion usually takes no more than 20 minutes.<\/p>\n\n<p style=\"text-align:justify\">During the procedure, you will need to apply cooling bags to the salivary glands, as Lutetium-177-DOTATATE partially accumulates in the salivary glands, affecting their function and causing dry mouth. You will also receive intravenous saline solutions and amino acid solutions to protect your kidneys.<\/p>\n\n<p style=\"text-align:justify\">After the infusion of Lutetium-177-DOTATATE, you will stay in a specially equipped (radiation-shielded) ward for 48 hours. The drug is quickly excreted by the kidneys, and after 48 hours you will no longer be dangerous to others. During these 48 hours, you can read, use a mobile phone, tablet or computer &ndash; all these devices will not be a source of radiation in the future.<\/p>\n\n<p style=\"text-align:justify\"><strong>Follow-up examinations<\/strong>&nbsp;include whole-body scintigraphy or computed tomography in 24 hours and 48 hours after the procedure. Based on the results of the examination, the doctor will determine whether one procedure is enough for you, or whether you will need to visit the hospital again. As a rule, 1-2 procedures are required for achieving a stable positive result. Procedures are carried out with an interval of 8 weeks.<\/p>\n<\/div><div class=\"program_required_documents mt-4\"><h4>Required documents<\/h4><ul>\n\t<li>Medical records<\/li>\n\t<li style=\"text-align: justify;\">MRI\/CT scan (not older than 3 months)<\/li>\n\t<li>Biopsy results (if available)<\/li>\n<\/ul>\n<\/div>","program_full_story_crm":"<ul>\n\t<li>Initial presentation in the hospital<\/li>\n\t<li>Clinical history taking<\/li>\n\t<li>Physical examination<\/li>\n\t<li>Laboratory tests:\n\t<ul>\n\t\t<li>complete blood count<\/li>\n\t\t<li>biochemical analysis of blood<\/li>\n\t\t<li>TSH, free T3, free T4<\/li>\n\t\t<li>indicators of inflammation<\/li>\n\t\t<li>coagulation tests<\/li>\n\t<\/ul>\n\t<\/li>\n\t<li>Renal scintigraphy<\/li>\n\t<li>Ga-68 DOTATATE PET\/CT (if indicated)<\/li>\n\t<li>Lutetium-177-DOTATATE treatment<\/li>\n\t<li>Full body scintigraphy after 24 hours<\/li>\n\t<li>Full body scintigraphy after 48 hours<\/li>\n\t<li>Symptomatic treatment<\/li>\n\t<li>Cost of essential medicines<\/li>\n\t<li>Nursing services<\/li>\n\t<li>Stay in the hospital with full board<\/li>\n\t<li>Accommodation in 2-bedded room<\/li>\n\t<li>Elaboration of further recommendations<\/li>\n<\/ul>\n<div class=\"program_how_program_going mt-4\"><h4>How program is carried out<\/h4><p style=\"text-align:justify\"><strong>During the first visit<\/strong>, the doctor will carry out a general physical examination and go through the results of previous laboratory and instrumental tests. After that, you will undergo the necessary additional tests such as the assessment of liver and kidney function, scintigraphy of the skeleton and salivary glands, somatostatin receptor imaging with&nbsp;Ga-68 DOTATATE PET\/CT. This will allow the doctor to assess how effective the radionuclide therapy with Lutetium-177-DOTATATE will be and how well you will tolerate it. Also, the doctor will calculate your individual dosage of the radionuclide.<\/p>\n\n<p style=\"text-align:justify\"><strong>Radionuclide therapy with Lutetium-177-DOTATATE<\/strong>&nbsp;is carried out via intravenous administration of a solution with the radioactive isotope Lutetium-177-DOTATATE. The solution is injected through a catheter. This is a short procedure, as the infusion usually takes no more than 20 minutes.<\/p>\n\n<p style=\"text-align:justify\">During the procedure, you will need to apply cooling bags to the salivary glands, as Lutetium-177-DOTATATE partially accumulates in the salivary glands, affecting their function and causing dry mouth. You will also receive intravenous saline solutions and amino acid solutions to protect your kidneys.<\/p>\n\n<p style=\"text-align:justify\">After the infusion of Lutetium-177-DOTATATE, you will stay in a specially equipped (radiation-shielded) ward for 48 hours. The drug is quickly excreted by the kidneys, and after 48 hours you will no longer be dangerous to others. During these 48 hours, you can read, use a mobile phone, tablet or computer &ndash; all these devices will not be a source of radiation in the future.<\/p>\n\n<p style=\"text-align:justify\"><strong>Follow-up examinations<\/strong>&nbsp;include whole-body scintigraphy or computed tomography in 24 hours and 48 hours after the procedure. Based on the results of the examination, the doctor will determine whether one procedure is enough for you, or whether you will need to visit the hospital again. As a rule, 1-2 procedures are required for achieving a stable positive result. Procedures are carried out with an interval of 8 weeks.<\/p>\n<\/div>","is_ambulant":"0","bh_fee":"0","only_for_children":"2","no_service":"0","with_prepayment":"1","show_calculator":"1","paket_type":"1","btn_type":"0","clinic_icon":"60004168eda58.jpg","city":"Halle","clinic_site":"http:\/\/www.medizin.uni-halle.de\/index.php?id=788","department_recommend":"1","country":"Germany","country_id":"1","clinic_name":"University Hospital Halle (Saale)","cinic_name":"University Hospital Halle (Saale)","department_id":"1694","duration":"5","direction":"Nuclear Medicine","min_duration":0,"clinic_id":"853","paketPrice":5800,"paket":"<ul>\n <li>Interpreter up to 15 hours<\/li>\n <li>Translation up to 10 pages<\/li>\n <li>Visa support<\/li>\n\n\n<\/ul>","title":"Treatment of neuroendocrine tumor (NET) of the appendix with Lutetium-177-DOTATATE","price":{"val":16052.08,"type":"val"},"price_surcharge":0,"price_surcharge_clear":0,"extra_service_clinic":[{"id":"need_to_use_head_doctor","title":"Treatment by leading experts","type":"val","val":"3895.31","req":0},{"id":"1_person_room","title":" Single room (whole period)","parent":"duration","type":"count_val","val":"68.00"},{"id":"2_person_room","title":" double room (whole period)","parent":"duration","type":"count_val","val":"90.00"},{"id":"attendant_place","title":"Accommodation for the accompanying person ","parent":"duration","type":"count_val","val":"90.00"}],"extra_service":[],"translation_hours":"0","translation_doc_count":null,"roads":[{"id":"20","distance":"31","airport_title":"Leipzig"},{"id":"21","distance":"152","airport_title":"Dresden"},{"id":"8","distance":"169","airport_title":"Berlin"}],"pakets":[],"lang":{"day":"Day","days":"days","ambulatory":"Outpatient","stationaryProgram":"Inpatient"}}

Treatment of neuroendocrine tumor (NET) of the appendix with Lutetium-177-DOTATATE

University Hospital Halle (Saale)

Halle, Germany
Program id # 691153
Doctor photo
Prof. Dr. med. Alexander Heinzel
Department of Nuclear Medicine
Specialized in: nuclear medicine

The program includes:

  • Initial presentation in the hospital
  • Clinical history taking
  • Physical examination
  • Laboratory tests:
    • complete blood count
    • biochemical analysis of blood
    • TSH, free T3, free T4
    • indicators of inflammation
    • coagulation tests
  • Renal scintigraphy
  • Ga-68 DOTATATE PET/CT (if indicated)
  • Lutetium-177-DOTATATE treatment
  • Full body scintigraphy after 24 hours
  • Full body scintigraphy after 48 hours
  • Symptomatic treatment
  • Cost of essential medicines
  • Nursing services
  • Stay in the hospital with full board
  • Accommodation in 2-bedded room
  • Elaboration of further recommendations

How program is carried out

During the first visit, the doctor will carry out a general physical examination and go through the results of previous laboratory and instrumental tests. After that, you will undergo the necessary additional tests such as the assessment of liver and kidney function, scintigraphy of the skeleton and salivary glands, somatostatin receptor imaging with Ga-68 DOTATATE PET/CT. This will allow the doctor to assess how effective the radionuclide therapy with Lutetium-177-DOTATATE will be and how well you will tolerate it. Also, the doctor will calculate your individual dosage of the radionuclide.

Radionuclide therapy with Lutetium-177-DOTATATE is carried out via intravenous administration of a solution with the radioactive isotope Lutetium-177-DOTATATE. The solution is injected through a catheter. This is a short procedure, as the infusion usually takes no more than 20 minutes.

During the procedure, you will need to apply cooling bags to the salivary glands, as Lutetium-177-DOTATATE partially accumulates in the salivary glands, affecting their function and causing dry mouth. You will also receive intravenous saline solutions and amino acid solutions to protect your kidneys.

After the infusion of Lutetium-177-DOTATATE, you will stay in a specially equipped (radiation-shielded) ward for 48 hours. The drug is quickly excreted by the kidneys, and after 48 hours you will no longer be dangerous to others. During these 48 hours, you can read, use a mobile phone, tablet or computer – all these devices will not be a source of radiation in the future.

Follow-up examinations include whole-body scintigraphy or computed tomography in 24 hours and 48 hours after the procedure. Based on the results of the examination, the doctor will determine whether one procedure is enough for you, or whether you will need to visit the hospital again. As a rule, 1-2 procedures are required for achieving a stable positive result. Procedures are carried out with an interval of 8 weeks.

Required documents

  • Medical records
  • MRI/CT scan (not older than 3 months)
  • Biopsy results (if available)

Service

Price:
Type of program :
Price for 1 day:
Expected duration of the program:
The minimum duration of the program:
Select

You may also book:

Guarantee Price:

About the department

The Department of Nuclear Medicine at the University Hospital Halle (Saale) offers the full range of services in this ​​medical field. It carries out all common and proven types of scintigraphic diagnostics and treatment. A unique offer of the department is SPECT-CT and PET-CT using various tracers and modern targeted radiopharmaceuticals. The department is headed by Prof. Dr. med. Alexander Heinzel.

The department has an in-house Section of Radiochemistry, in which all the necessary radiopharmaceuticals for the diagnostics and therapy are synthesized. Thus, the department has all the resources to provide excellent medical service.

The diagnostic options of the department include:

  • Combined positron emission tomography with computed tomography (PET-CT)
  • Gastrointestinal scintigraphy to find the source of bleeding, detect Meckel's diverticulum
  • Myocardial perfusion scintigraphy
  • Brain scintigraphy (neuro-SPECT, DaTSCAN ™ and IBZM-SPECT)
  • Bone scintigraphy
  • Functional liver scintigraphy
  • Scintigraphy using anti-granulocyte antibodies and labeled white blood cells
  • Cerebrospinal fluid scintigraphy
  • Ventilation and perfusion lung scintigraphy
  • Gastric emptying scintigraphy
  • Parathyroid scintigraphy
  • Renal function scintigraphy and static kidney scintigraphy
  • Thyroid diagnostics
    • Thyroid scintigraphy
    • MIBI thyroid scintigraphy
    • Imaging-guided fine needle aspiration biopsy
  • Sentinel lymph node marking
  • Esophageal scintigraphy
  • 123I-mIBG or 111In-octreotide tumor scintigraphy (Octreoscan)
  • Radioimmunological analysis within the framework of the in-house laboratory
  • Other diagnostic services

The therapeutic options of the department include:

  • Radioiodine therapy
    • Benign thyroid diseases
      • Hyperthyroidism due to hormonally active autonomous thyroid nodules (unifocal, multifocal autonomy)
      • Hyperthyroidism due to Graves' disease
      • Enlarged thyroid gland (goiter)
    • Malignant thyroid diseases
      • Differentiated thyroid cancer (follicular and papillary cancer)
      • Other types of recurrent thyroid cancer
  • Radiosynoviorthesis
    • Rheumatoid arthritis
    • Arthrosis of the large joints
    • Conditions after synovectomy
    • Seronegative spondyloarthropathy
    • Crystal arthropathy
    • Villonodular synovitis
    • Arthropathy in hemophilia
  • Selective internal radiotherapy for liver tumors
  • Peptide receptor radionuclide therapy for patients with metastatic neuroendocrine tumors
  • PSMA therapy for patients with metastatic prostate cancer
  • Other therapeutic methods

Curriculum vitae

Prof. Dr. med. Alexander Heinzel has been the Head Physician of the Department of Nuclear Medicine at the University Hospital Halle (Saale) since October 1, 2022. Prior to that, he worked as a Senior Physician in the Department of Nuclear Medicine at the University Hospital RWTH Aachen.

Prof. Heinzel has been actively involved in teaching activities for many years and received his Master of Medical Education (MME) in 2020. Since 2019, he has also been a Member of the Continuing Education Committee of the German Society of Nuclear Medicine (DGN). In 2020, he was appointed as an Expert at the Institute for Medical and Pharmaceutical Proficiency (IMPP).

Prof. Alexander Heinzel graduated from the Heinrich Heine University Duesseldorf and the University of Nantes (France). In 2011, he underwent habilitation at Heinrich Heine University Duesseldorf. Since 2020, Dr. med. Heinzel has held the position of Extraordinary Professor for Nuclear Medicine at the RWTH Aachen University.

Фото врача: (c) Universitätsklinikum Halle (Saale)


About hospital

According to the prestigious Focus magazine, the University Hospital Halle (Saale) ranks among the top German medical facilities!

The history of the hospital has more than 300 years, and during this time it managed to earn an excellent reputation not only in Germany, but throughout the world. The hospital positions itself as a specialized medical facility for the treatment of very severe and rare diseases and injuries. It provides medical care for patients of all age groups in accordance with the very latest scientific achievements. It is worth noting that the hospital is characterized by its successful research activities, especially in the field of cardiovascular diseases and oncopathology. The specialists of these fields have made a significant contribution to the development of new diagnostic methods and therapeutic approaches.

The hospital diagnoses and treats more than 40,000 inpatients and about 120,000 outpatients every year. Such a large number of patients indicates the reliability and effectiveness of medical services.

Some structural units of the hospital deserve special attention. For example, the Central Department of Emergency Medical Care (the largest in Saxony-Anhalt), modern dental rooms, the Perinatal Center and the Transplant Center with a history of more than 40 years.

Thanks to the use of the cutting-edge medical technology and the availability of advanced equipment, many operations and procedures, which previously could entail a lot of risks and consequences, are currently performed in the hospital with the help of sparing techniques. In this context, it is worth noting hybrid heart interventions, robotic interventions in urology (da Vinci surgical system), etc.

In addition, the key to successful clinical practice is the availability in the hospital of experienced and competent medical staff. The total number of medical staff includes more than 4,000 medical employees. Many doctors are known far beyond the borders of Germany, they regularly carry out significant researches, which allow them to develop modern medicine. In addition, the hospital specializes in training of medical students, therefore the qualified doctors and professors are willing to pass on their experience to the younger generation.

Photo: (c) depositphotos

Accommodation in hospital

Patients rooms

The patients of the University Hospital Halle (Saale) live in comfortable single, double and triple patient rooms made in a modern design. All patient rooms are equipped with an ensuite bath with toilet and shower. The standard room includes a comfortable, automatically adjustable bed, a bedside table, a wardrobe, a table and chairs for receiving visitors and a TV. There is access to Wi-Fi. For security reasons, in some places, including in Intensive Care Units, it is forbidden to use laptops and mobile phones. In addition, the hospital offers enhanced-comfort patient rooms.

Meals and Menus

The patient and his accompanying person have a daily choice of three menus. If for any reason you do not eat all the food, you will be offered an individual menu. Please inform the medical staff about your dietary preferences prior to the treatment. Children are offered a special menu with healthy and tasty dishes, rich in nutrients necessary for the growing body.

Further details

Standard rooms include:

Toilet
Shower
Wi-Fi
TV

Religion

Religious services are available upon request.

Accompanying person

During the inpatient program, an accompanying person may stay with you in a patient room or hotel of your choice.

Hotel

During the outpatient program, you may stay in a hotel of your choice. Managers will help you choose the most suitable options.